Thank you for your interest in participating in the 2026 STI Prevention Conference! Symposium abstracts will be reviewed on a rolling basis, so we encourage early submission. Please note that deadline extensions will not be granted.
February: Abstract and Symposium Proposal Submission Opens
April 1, 2026: Symposium Proposal Closed
May 1, 2026: Abstract Submission Closes
June 1, 2026: Speakers notified of acceptance
The STI Prevention Conference invites submissions for 90-minute symposia that advance science, practice, policy, and community-driven approaches to STI prevention.
Symposium abstracts will be reviewed on a rolling basis, so we encourage early submission. Please note that deadline extensions will not be granted.
Proposed symposium sessions should be engaging, interactive, and relevant to real-world STI prevention challenges. Symposiums are expected to also feature multiple perspectives organized around a unifying theme and include intentional opportunities for audience participation.
The conference values sessions that:
- Address health equity and the needs of communities disproportionately impacted by STIs
- Integrate perspectives across research, clinical care, public health practice, policy, advocacy, and lived experiences within the session
- Encourage active participation through discussion, case examples, or other interactive formats
- Highlight diverse speakers across disciplines, sectors, career stages, and backgrounds.
Submitters should clearly describe session objectives, structure, planned interactivity, and how the proposed speakers and content reflect these values.
Required information for submission
- Session Title (<150 characters):
- Primary Topic Area(s) : STI prevention & control, Diagnostics & screening, Treatment & clinical care, Implementation science, Health equity & social determinants, Community engagement & lived experience, Policy, funding & systems change, Surveillance, data & epidemiology, Work development, Other
- Learning Objectives: List 3 measurable learning objectives using the format of “By the end of this session, participants will be able to…”
- Session Structure & Interactivity (<300 words): Outline how the 90 minutes will be structured and how participants will be actively engaged. Interactivity is required for these sessions. Include timing of interactive elements such as: Facilitated discussion, Case- or scenario-based discussion, Polling or audience response, or Small-group or paired activities
- Equity and Community Relevance (<200 words): Describe how the proposed session: Addresses health equity and populations disproportionately impacted by STIs, Incorporates diverse perspectives, disciplines, sectors, geographies, or lived experience, Reflects community-informed or real-world approaches
- Intended Audience: Clinicians, Public health practitioners, Researchers, Community-based organizations, Advocates, Policy makers, Early-career professionals/trainees, Other
- Suggested Presenters (up to 4): The conference encourages diverse speakers across work areas, sectors, career stages, and lived experiences. For each presenter, provide: Name, Affiliation/organization, Primary perspective or work area that presenter brings to this session, Role in session (presenter, panelist, facilitator, organizer), Email
The Program Committee invites abstracts of high quality in the areas of STI prevention research, program, policy, diagnosis, and treatment. Abstract submissions are peer-reviewed for scientific content, logical presentation, timeliness, and current interest of the topic to the scientific and STI Prevention community.
Submission of an abstract implies the commitment that the presenting author registers for the 2026 STI Prevention Conference and has adequate financial resources to attend the conference.
Abstracts must be submitted electronically through the abstract submission portal. Abstracts sent by mail, fax or email will NOT be accepted. Abstracts and any amendments to submitted abstracts will not be accepted after the submission deadline. No extensions will be given.
Submitted abstracts must:
- Reflect work where data collection ended in 2025 or 2026. This information must be included in the abstract methods section to be considered for presentation.
- Not have been published in a peer reviewed journal prior to June 21, 2026.
Abstracts previously presented at meetings will not be accepted unless there is a substantial update of data. Multiple abstracts reporting results from the same study and overlapping abstracts from the same group of investigators are strongly discouraged.
General Abstract Format
- Abstracts (300 words in length) should contain the following four components: 1) Background: a concise statement of the issue under investigation or a hypothesis; 2) Methods: the methods used (including the statistical analyses employed); 3) Results: specific findings (promises such as “to be completed” or “to be presented” are not acceptable; no figures or tables); and 4) Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as “the results will be discussed” are not acceptable).
- Do not include grant acknowledgements, literature references, or copyright or trademark symbols.